Phages Adepte SRL
Phages Adepte reported total assets of 18,274 € at the end of the 2025 financial year (annual accounts filed with the NBB on 21 Aug 2026).
The score of Phages Adepte shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Phages Adepte's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Aug 2026
- Year ended 31 Dec 2024filed on 25 Aug 2025
Phages Adepte's financial analysis
- Solvency65.5%sector median: 45.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Phages Adepte
Phages Adepte's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1006.761.614
- VAT number
- BE1006761614
- Peppol
- Registered · 0208:1006761614 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Mar 2024
- Registered office
- 1190 Forest
- Latest accounts
- 2025 · filed on 21 Aug 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Phages Adepte (SRL) has been based in Forest since 2024, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 10,288 € and equity of 11,976 €; its revenue is not published. Its solvency stands at 65.5%, above the median of its sector (45.7%).
Companies similar to Phages Adepte
Companies in the same business, of comparable size and area, outside its group.
- Lipofabrik Belgium Research and experimental development on natural sciences and engineering Gembloux · balance sheet 23,877 €
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- Allsightsafrica Research and experimental development on natural sciences and engineering Orp-Jauche · balance sheet 30,275 €
- Yagh Penn Consulting Research and experimental development on natural sciences and engineering Bertem · balance sheet 34,428 €
- Consultbio Research and experimental development on natural sciences and engineering Rumst · balance sheet 106,674 €
- Biograbbit Research and experimental development on natural sciences and engineering Dendermonde · balance sheet 61,503 €
- JN-RD Research and experimental development on natural sciences and engineering Oreye · balance sheet 67,834 €
- Aquature Technologies Research and experimental development on natural sciences and engineering Antwerp · balance sheet 122,734 €
Frequently asked questions about Phages Adepte
What is the revenue of Phages Adepte?
Phages Adepte files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Phages Adepte?
In Belgium, the VAT number is the company number prefixed with BE: BE1006761614 for Phages Adepte, if the company is VAT-registered. Its company number (CBE) is 1006.761.614.
Where is the registered office of Phages Adepte?
According to the CBE register, the registered office of Phages Adepte is in 1190 Forest.
What is the equity of Phages Adepte?
At the close of the 2025 financial year, the equity of Phages Adepte amounts to 11,976 €, a solvency of 65.5% of total assets.
Who manages Phages Adepte?
The register lists 1 active mandates at Phages Adepte. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Phages Adepte
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →